AI-generated summary
The authors studied whether lowering tryptophan, which reduces brain serotonin levels, would cause depressive symptoms to return in patients with seasonal affective disorder who were in natural summer remission. Twelve drug-free patients and ten normal subjects took part in a double-blind, placebo-controlled crossover study. The authors report significant plasma tryptophan reduction but no significant behavioural effect compared with the control session.
- Who or what was studied
- Twelve drug-free patients with seasonal affective disorder in natural summer remission and 10 normal subjects
- Limits stated in the abstract
- The sample was small, and the authors note their results conflict with other laboratories, possibly due to differences in study samples.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on cambridge.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Placebo-controlled, Crossover study, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.